- Home
- MGTX vs AAM Comparison
MGTX vs AAM Comparison
Compare MGTX & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- AAM
- Stock Information
- Founded
- MGTX 2015
- AAM 2024
- Country
- MGTX United States
- AAM United States
- Employees
- MGTX N/A
- AAM N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- AAM
- Sector
- MGTX Health Care
- AAM
- Exchange
- MGTX Nasdaq
- AAM Nasdaq
- Market Cap
- MGTX 520.8M
- AAM 457.8M
- IPO Year
- MGTX N/A
- AAM 2024
- Fundamental
- Price
- MGTX $6.34
- AAM $10.42
- Analyst Decision
- MGTX Strong Buy
- AAM
- Analyst Count
- MGTX 2
- AAM 0
- Target Price
- MGTX $24.00
- AAM N/A
- AVG Volume (30 Days)
- MGTX 451.7K
- AAM 32.6K
- Earning Date
- MGTX 08-11-2025
- AAM 01-01-0001
- Dividend Yield
- MGTX N/A
- AAM N/A
- EPS Growth
- MGTX N/A
- AAM N/A
- EPS
- MGTX N/A
- AAM 0.30
- Revenue
- MGTX $34,508,000.00
- AAM N/A
- Revenue This Year
- MGTX $365.04
- AAM N/A
- Revenue Next Year
- MGTX $73.18
- AAM N/A
- P/E Ratio
- MGTX N/A
- AAM $34.77
- Revenue Growth
- MGTX 203.23
- AAM N/A
- 52 Week Low
- MGTX $3.85
- AAM $9.96
- 52 Week High
- MGTX $8.75
- AAM $10.79
- Technical
- Relative Strength Index (RSI)
- MGTX 55.84
- AAM N/A
- Support Level
- MGTX $6.21
- AAM N/A
- Resistance Level
- MGTX $6.76
- AAM N/A
- Average True Range (ATR)
- MGTX 0.39
- AAM 0.00
- MACD
- MGTX 0.08
- AAM 0.00
- Stochastic Oscillator
- MGTX 63.40
- AAM 0.00
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About AAM AA Mission Acquisition Corp. Class A Ordinary Shares
AA Mission Acquisition Corp is a blank check company.